Compared to Semaglutide and Tirzepatide, retatrutide's unique inclusion of glucagon receptor agonism along with GIP and GLP-1 receptor agonism features a definite pharmacological profile. Although Semaglutide is often a GLP-1 receptor agonist and Tirzepatide brings together GLP-one and GIP receptor agonism, retatrutide's triple system could likely give broader metabolic benefits. https://corepepptides.com/product/retatrutide-injection-pen/